Large-Company Funds
When Will Danoff's Fidelity Contrafund (symbol FCNTX) reopened to new investors, we quickly added it to the Kiplinger 25 roster.
When Will Danoff's Fidelity Contrafund (symbol FCNTX) reopened to new investors, we quickly added it to the Kiplinger 25 roster. Since taking over Contrafund in September 1990, Danoff has piloted this large-company growth fund to an annualized return of 11%, beating Standard & Poor's 500-stock index by an impressive average of five percentage points per year.
Danoff searches for innovative market leaders with high returns on capital. He'll pay "a fair price for a great company," he says, especially when that company is gaining share of a market in which barriers to entry are high. Recently, Danoff has gravitated toward defensive stocks, such as Coca-Cola and Johnson & Johnson.
When Brian Rogers is taking on more risk, it's time to pay attention. Rogers, manager of T. Rowe Price Equity Income (PRFDX) and chairman of the Baltimore-based fund house, is as steady and sober as they come. Since Price launched Equity Income in 1985 with Rogers at the helm, the fund has done as well as the S&P 500, returning 8% a year but with lower volatility than the index. That is no small feat.

Sign up for Kiplinger’s Free E-Newsletters
Profit and prosper with the best of expert advice on investing, taxes, retirement, personal finance and more - straight to your e-mail.
Profit and prosper with the best of expert advice - straight to your e-mail.
Rogers has been trimming his holdings of consumer stocks, such as Procter & Gamble and General Mills, while snapping up shares in more economically sensitive companies, including Boeing, Deere and Nucor. "When prices of good-quality companies are down 50% or more, it makes sense to invest in controversial sectors," says Rogers.
Mason Hawkins, the crusty bargain-hunting veteran who co-manages Longleaf Partners (LLPFX), is excited. He says stocks of the best businesses in the world are the cheapest they've been in 75 years. "The market is voting fearfully today because no one knows when the global economy will stabilize," he says.
One of Hawkins's favorite measures is free-cash-flow yield (a company's free cash flow divided by its market capitalization) relative to the yield on Treasuries. On that basis, many of Longleaf's large holdings, such as Dell, Disney and DirecTV, yield more than 10%, compared with the 3% yield of ten-year Treasury notes. Share prices, he says, reflect a huge amount of fear, "giving you the opportunity you want as a long-term shareholder."
As the third-generation member of his family to manage money, Chris Davis takes the long view in his role running Selected American Shares (SLASX). He offers the case of Johnson & Johnson, a stock he holds that has fallen by 23% over the past year. "Do I think J&J is much riskier, the earnings prospects worse, or its competitive advantage lower? No, I don't think so."
J&J and Procter & Gamble are global stalwarts, one category of holdings in Selected, which Davis manages with Ken Feinberg. A second category is cash-rich companies, such as Berkshire Hathaway, that can make savvy acquisitions and play a bit of offense in these chaotic capital markets. Another Davis strategy is to invest in beneficiaries of the growing global middle class. The last bucket is in stocks with "headline risk." These days, that mostly means financials.
The six men who run Vanguard Primecap Core (VPCCX) don't speak to the press. Instead, they let the results of their fine fund do the talking. They focus on growing companies but are value-oriented in their stock picking. Moreover, their portfolio turnover rate is exceptionally low for a growth fund. Primecap steered clear of the debacle in financials and instead loaded up on health-care stocks, such as Eli Lilly and Amgen, and technology companies, such as Oracle.
It's interesting that both growth- and value-oriented funds are loading up on health-care stocks. Dodge & Cox Stock (DODGX), on the value end of the spectrum, has 28% of its portfolio in the sector, double the S&P 500's weight. Charles Pohl, one of nine co-managers, says that health-care stocks are unusually cheap, given the potential for growth both at home and abroad and the opportunity for drug makers, in particular, to boost profitability by becoming more efficient.
Commodity Funds
Profit and prosper with the best of Kiplinger's advice on investing, taxes, retirement, personal finance and much more. Delivered daily. Enter your email in the box and click Sign Me Up.
Andrew Tanzer is an editorial consultant and investment writer. After working as a journalist for 25 years at magazines that included Forbes and Kiplinger’s Personal Finance, he served as a senior research analyst and investment writer at a leading New York-based financial advisor. Andrew currently writes for several large hedge and mutual funds, private wealth advisors, and a major bank. He earned a BA in East Asian Studies from Wesleyan University, an MS in Journalism from the Columbia Graduate School of Journalism, and holds both CFA and CFP® designations.
-
How to Invest as the AI Industry Grows Up
Here’s where to find the winners as artificial intelligence transitions from an emerging technology to an adolescent one.
-
I’m 62 and worried about Social Security’s future. Should I take it early?
A Social Security shortfall may be coming soon. We ask financial experts for guidance.
-
Stock Market Today: Stocks Slip Ahead of Big Earnings, Inflation Week
Perhaps uncertainty about tariffs, inflation, interest rates and economic growth can only be answered with earnings.
-
Stock Market Today: Solid Signals Lift Stocks Despite Tariff Noise
Markets are whistling over the White House in an ongoing display of corporate America's enduring ability to survive and advance.
-
Stock Market Today: Trump's Copper Comments Cause a Stir
Markets remain resilient and monetary policy makers stand fast against a rising tide of new terms of trade, including around copper.
-
Stock Market Today: Trump Reextends His Tariff Deadline
When it comes to this president, his trade war, the economy, financial markets and uncertainty, "known unknowns" are better than "unknown unknowns."
-
Stock Market Today: President Trump Reboots the Tariff Trade
A broad consensus that markets hate uncertainty more than anything else is being tested on an almost daily basis in 2025.
-
Stock Market Today: It's 'Most Sectors Go' Ahead of Independence Day
The resilience trade continues to work, even for sectors and stocks with specific uncertainties.
-
Stock Market Today: S&P 500, Nasdaq Hit New Highs After Vietnam Trade Deal
Ahead of a key July 9 tariff deadline, President Trump said the U.S. has reached a trade deal with Vietnam.
-
Stock Market Today: Another Quarter, More Mixed Price Action
"Up and to the right" remains the general trend despite persistent uncertainty around critical policy issues.